MHRA grants approval of Sanofi’s Sarclisa (isatuximab) subcutaneous (SC) as the UK’s first anticancer treatment administered via an on-body injector (OBI)
Sanofi is pleased to announce that the United Kingdom (UK) Medicines and Healthcare products Regulatory agency (MHRA) has granted marketing authorisation for Sarclisa (isatuximab) for subcutaneous (SC) use in combination […]
Careology launches tech-enabled cancer care navigation at Guy’s and St Thomas’ NHS Foundation Trust
Careology, the leading international digital cancer care platform, has teamed up with Boots to provide additional support, care and advice for patients with cancer. The collaboration, which is available initially […]
AbbVie’s First in Class Therapy ELAHERE® ▼ (mirvetuximab soravtansine) Licensed by the Medicines and Healthcare products Regulatory Agency for the Treatment of Eligible Adult Patients with Platinum-Resistant Ovarian Cancer
AbbVie has announced it has received marketing authorisation from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for ELAHERE® (mirvetuximab soravtansine) as monotherapy for the treatment of eligible adult […]
Essential Pharma acquires Renaissance Pharma Ltd with its clinical stage immunotherapy for the treatment of high-risk neuroblastoma
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically differentiated, niche pharmaceutical products across key therapeutic areas, announces that it […]
Jemperli▼ (dostarlimab) becomes the first immunotherapy treatment to receive NICE recommendation for use, in line with its license, in eligible endometrial cancer patients in first line setting
GSK plc has announced this week that NICE has published a final draft guidance recommending the use of dostarlimab in combination with platinum-containing chemotherapy for the treatment of adult patients […]
‘Protein sandwich’ could transform cancer drug discovery
A breakthrough class of molecular glue identified at the University of Dundee could pave the way for a new generation of drugs to target cancers and neurodegenerative diseases. A research […]
New AI collaboration could advance precision therapy in breast cancer
A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer […]
Shortage of leading painkillers continues into the New Year
Pharmacists are continuing to experience a shortage of Zapain®, co-codamol 30/500mg tablets, which are currently out of stock via leading distributor and wholesale supplier Alliance Healthcare. More than 500,000 patients […]
Painkiller supply issues worsen as leading manufacturer is partially suspended
Pharmacists nationwide are grappling with an escalating shortage of co-codamol as Bristol Laboratories faces suspensions from the Medicine & Healthcare products Regulatory Agency (MHRA). The key manufacturer has been named […]
National Shortage of leading branded painkiller
Pharmacists are currently experiencing a shortage of Zapain®, co-codamol 30/500mg tablets, across the UK. More than 500,000 patients are prescribed the drug every month, making it the number one selling […]
